HK Stock MarketDetailed Quotes
01244 3D MEDICINES
- 3.300
- +0.690+26.44%
Trading Dec 12 14:00 CST
852.08MMarket Cap-1.73P/E (TTM)
3.490High2.480Low4.32MVolume2.540Open2.610Pre Close13.54MTurnover1.67%Turnover RatioLossP/E (Static)258.21MShares8.45052wk High0.92P/B852.08MFloat Cap1.60052wk Low--Dividend TTM258.21MShs Float131.500Historical High--Dividend LFY38.70%Amplitude1.600Historical Low3.137Avg Price500Lot Size--Div YieldTTM--Div Yield LFY
3D MEDICINES Key Stats
All
YOY
| (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (FY)Dec 31, 2020 | (FY)Dec 31, 2019 | |
|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||
| Earning before tax | 40.03%-114.07M | 46.54%-562.47M | 41.21%-190.2M | 28.03%-1.05B | ---323.55M | -130.07%-1.46B | -98.29%-635.38M | ---320.43M |
| Profit adjustment | ||||||||
| Interest (income) - adjustment | -117.75%-6.15M | 9.42%-6.53M | -10.41%-2.82M | -31.04%-7.21M | ---2.56M | -241.74%-5.5M | -1,025.87%-1.61M | ---143K |
| Investment loss (gain) | -16.43%-7.05M | -577.58%-12.94M | -957.07%-6.06M | -350.24%-1.91M | ---573K | -171.79%-424K | -609.09%-156K | ---22K |
| Impairment and provisions: | 1,622.38%4.77M | -171.23%-837K | 174.26%277K | 803.85%1.18M | --101K | --130K | ---- | ---- |
| -Other impairments and provisions | 1,622.38%4.77M | -171.23%-837K | 174.26%277K | 803.85%1.18M | --101K | --130K | ---- | ---- |
| Revaluation surplus: | -92.88%-3.52M | -101.12%-7.38M | -101.27%-1.83M | -31.17%657M | --143.5M | 199.02%954.56M | 24,102.58%319.23M | --1.32M |
| -Other fair value changes | -92.88%-3.52M | -101.12%-7.38M | -101.27%-1.83M | -31.17%657M | --143.5M | 199.02%954.56M | 24,102.58%319.23M | --1.32M |
| Asset sale loss (gain): | ---- | ---- | ---- | ---- | ---- | 47,850.00%959K | -33.33%2K | --3K |
| -Loss (gain) on sale of property, machinery and equipment | ---- | ---- | ---- | ---- | ---- | 47,850.00%959K | -33.33%2K | --3K |
| Depreciation and amortization: | 8.28%15.54M | 17.88%25.46M | 31.86%14.35M | 71.55%21.6M | --10.88M | 273.51%12.59M | 44.49%3.37M | --2.33M |
| -Amortization of intangible assets | 0.00%51K | 0.00%101K | 0.00%51K | 20.24%101K | --51K | --84K | ---- | ---- |
| Financial expense | 25.23%5.06M | 149.66%7.77M | 329.19%4.04M | 103.73%3.11M | --942K | -81.04%1.53M | -47.01%8.06M | --15.21M |
| Exchange Loss (gain) | 57.44%-3.48M | 107.33%2.55M | 62.23%-8.18M | -1,042.42%-34.86M | ---21.65M | -37.59%3.7M | 908.59%5.93M | ---733K |
| Special items | -85.90%15.33M | 110.99%298.96M | 70.51%108.75M | -9.80%141.69M | --63.78M | 37,659.62%157.08M | -98.40%416K | --26.07M |
| Operating profit before the change of operating capital | -14.57%-93.57M | 5.91%-255.4M | 36.76%-81.66M | 19.51%-271.43M | ---129.13M | -12.35%-337.2M | -8.59%-300.14M | ---276.4M |
| Change of operating capital | ||||||||
| Inventory (increase) decrease | 48.59%-3.42M | -188.76%-3.42M | -310.36%-6.65M | -9,000.00%-1.18M | ---1.62M | ---13K | ---- | ---- |
| Accounts receivable (increase)decrease | 41.17%-32.3M | 656.57%72.71M | -25.62%-54.91M | 79.83%-13.06M | ---43.71M | -21,705.39%-64.76M | -371.43%-297K | ---63K |
| Accounts payable increase (decrease) | -28.95%-20.76M | -110.27%-9.91M | -121.52%-16.1M | 184.65%96.52M | --74.83M | 870.44%33.91M | -109.61%-4.4M | --45.79M |
| prepayments (increase)decrease | 30.01%-4.31M | 133.77%34.12M | -345.32%-6.16M | -2,478.18%-101.04M | --2.51M | -122.73%-3.92M | 1,775.70%17.24M | ---1.03M |
| Special items for working capital changes | -857.60%-25.25M | ---- | ---2.64M | ---- | ---- | ---- | ---- | ---- |
| Cash from business operations | -6.84%-179.61M | 44.21%-161.9M | -73.10%-168.12M | 21.99%-290.2M | ---97.12M | -29.34%-371.99M | -24.12%-287.6M | ---231.71M |
| Other taxs | ---55K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Special items of business | ---- | 53.21%17.49M | ---- | 324.19%11.42M | --11.57M | -154.95%-5.09M | 196.57%9.27M | ---9.6M |
| Net cash from operations | -6.87%-179.67M | 48.20%-144.41M | -96.51%-168.12M | 26.07%-278.78M | ---85.55M | -35.48%-377.08M | -15.34%-278.33M | ---241.3M |
| Cash flow from investment activities | ||||||||
| Interest received - investment | 13.83%6.13M | -9.05%6.43M | 66.49%5.39M | 28.93%7.07M | --3.24M | 240.50%5.48M | 1,025.87%1.61M | --143K |
| Loan receivable (increase) decrease | ---- | ---- | ---- | 77.34%-997K | ---- | ---4.4M | --0 | ---- |
| Decrease in deposits (increase) | ---- | ---- | ---- | --0 | ---201.34M | 200.00%6M | ---6M | ---- |
| Sale of fixed assets | ---- | ---- | ---- | ---- | ---- | ---- | --4K | ---- |
| Purchase of fixed assets | -724.61%-45.93M | 88.28%-6.32M | 69.03%-5.57M | -23.04%-53.98M | ---17.99M | -293.58%-43.87M | -21,336.54%-11.15M | ---52K |
| Purchase of intangible assets | ---- | ---- | ---- | ---- | ---- | ---12.51M | ---- | ---- |
| Acquisition of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---- | ---11.12M | ---- |
| Recovery of cash from investments | -32.14%102.82M | -10.28%238.46M | 51.52%151.52M | 427.08%265.77M | --100M | 717.11%50.42M | -69.18%6.17M | --20.02M |
| Cash on investment | 71.60%-50M | 7.35%-426.14M | -76.06%-176.06M | -359.97%-459.97M | ---100M | ---100M | ---- | ---6M |
| Net cash from investment operations | 152.66%13.02M | 22.52%-187.58M | 88.56%-24.73M | -144.87%-242.11M | ---216.1M | -382.77%-98.87M | -245.11%-20.48M | --14.11M |
| Net cash before financing | 13.59%-166.64M | 36.26%-331.99M | 36.07%-192.84M | -9.44%-520.89M | ---301.65M | -59.28%-475.95M | -31.52%-298.81M | ---227.19M |
| Cash flow from financing activities | ||||||||
| New borrowing | 5.78%134.98M | 62.78%242.6M | 607.08%127.6M | --149.04M | --18.05M | ---- | -98.45%3.52M | --227.95M |
| Refund | -158.79%-135.85M | -680.71%-149.42M | ---52.49M | -443.41%-19.14M | ---- | 97.43%-3.52M | 58.97%-136.9M | ---333.65M |
| Issuing shares | ---- | -30.99%216.37M | --8.99M | -80.58%313.52M | ---- | 105.97%1.61B | 98.27%783.82M | --395.34M |
| Interest paid - financing | -7.48%-4.15M | 24.66%-1.44M | -316.38%-3.86M | -25.00%-1.91M | ---928K | 91.29%-1.53M | -144.36%-17.53M | ---7.18M |
| Absorb investment income | ---- | --20M | ---- | ---- | ---- | --332.78M | ---- | ---- |
| Issuance expenses and redemption of securities expenses | 81.09%-160K | 70.13%-6.75M | 21.88%-846K | 97.92%-22.59M | ---1.08M | -3,423.90%-1.09B | ---30.84M | ---- |
| Other items of the financing business | ---- | 40.19%3.06M | -74.88%205K | 138.75%2.18M | --816K | -186.04%-5.63M | --6.55M | ---- |
| Net cash from financing operations | -116.11%-12.29M | -25.44%304.51M | 584.39%76.28M | -51.38%408.41M | --11.15M | 38.31%840.08M | 116.29%607.39M | --280.82M |
| Effect of rate | -67.87%1.16M | -107.98%-2.79M | -83.81%3.61M | 954.07%34.91M | --22.32M | 36.86%-4.09M | -794.53%-6.47M | --932K |
| Net Cash | -53.51%-178.94M | 75.57%-27.48M | 59.88%-116.56M | -130.89%-112.47M | ---290.5M | 18.00%364.13M | 475.38%308.58M | --53.63M |
| Begining period cash | -4.34%666.47M | -10.02%696.74M | -10.02%696.74M | 86.91%774.31M | --774.31M | 269.36%414.26M | 94.74%112.16M | --57.59M |
| Cash at the end | -16.29%488.7M | -4.34%666.47M | 15.35%583.79M | -10.02%696.74M | --506.12M | 86.91%774.31M | 269.36%414.26M | --112.16M |
| Cash balance analysis | ||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | Unqualified Opinion | Unqualified Opinion |
| Auditor | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | Ernst & Young | Ernst & Young |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
HK
Overall
Symbol
Price
% Chg
No Data
